October 2019: Guyana launches revised 14-day MDA against LF

In the last week of October, Guyana launched a revised 14-day mass drug administration event against lymphatic filariasis, adding four additional endemic regions to the scope and switching to a three-drug therapy of ivermectin, diethylcarbamazine and albendazole (IDA). Guyana and Haiti are the only two countries in the Americas which have not eliminated the disease. Guyana DPI